Filing Details
- Accession Number:
- 0001104659-24-068673
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-05 16:07:38
- Reporting Period:
- 2024-06-03
- Accepted Time:
- 2024-06-05 16:07:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1773427 | Springworks Therapeutics Inc. | SWTX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1786966 | Badreddin Edris | C/O Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-06-03 | 11,772 | $39.40 | 257,828 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-03 | 4,192 | $40.62 | 253,636 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-03 | 3,651 | $41.38 | 249,985 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-03 | 385 | $42.04 | 249,600 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.98 to $39.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.98 to $40.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.98 to $41.955. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.99 to $42.065. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.